A Strip of Adhesive, a UFC Sponsorship, and an Affiliate Link
Somewhere between the sleep-tracking ring and the magnesium powder, the wellness internet decided that the problem with your night was your mouth being open.
The fix is a strip of adhesive across the lips. It costs somewhere between twenty-five cents and a dollar-fifty per night depending on whose brand you buy, and it is now sold by companies with real revenue and real sponsorship deals. Hostage Tape, founded by a former Arena Football League quarterback, went from roughly $900,000 in revenue in 2022 to a reported $40 million projected for 2024, self-funded, on essentially nothing but Meta ads. In April 2024 it became the official sleep aid partner of the UFC. Gwyneth Paltrow has recommended a competitor on Instagram as the single best wellness tool she'd found recently, and goop now stocks a mouth tape of its own. Erling Haaland told a podcast he sleeps with his mouth taped. The Skinny Confidential sold out a $35 tin of lip-shaped mouth-tape stickers in forty-eight hours.
You will read constantly that this is a billion-dollar industry. It isn't, yet. That figure traces back to a founder telling a business outlet his company was on track to reach a billion — a growth target that got laundered into a market statistic through repetition. The only published estimate I could find puts the global mouth tape market at roughly $180 million in 2024, projected to reach $330 million by 2030. That's a real business. It's about a fifth of the number in the headlines.
Here is the detail that explains the whole phenomenon better than any sales figure. In October 2023, the Huberman Lab newsletter published a breathwork protocol guide. Under the heading for sleep apnea, in a numbered list of treatment options, item one was a CPAP machine. Item two was to sleep with medical tape on the mouth to force nasal breathing. The words "medical tape" were an Amazon affiliate link.
A named Stanford scientist, listing tape as a treatment option for a disease that kills people, monetized, with no contraindication on that line. That is the trend's entire distribution mechanism compressed into one hyperlink — and I want to be precise that the problem isn't the affiliate revenue. It's the category error. Mouth tape got shelved next to CPAP, and once something is on that shelf, people stop asking what the evidence is.
So let's ask.
Seven Promises, and What Was Actually Measured
Scroll the marketing and the claims sort into roughly seven buckets: better sleep quality, less snoring, treated sleep apnea, a sharper and more defined jawline, better skin, fewer cavities and less bad breath, and more energy with less brain fog.
Now here is the number that reframes the entire category. Across every study of mouth taping ever published, in any language, of any design, the outcomes measured are: apnea-hypopnea index, snoring index, oxygen desaturation index, Epworth sleepiness scores, and mouth leak during positive-airway-pressure therapy.
That's it. Not one study has ever measured skin. Not one has measured facial structure or jawline definition. Not one has measured energy, cognition, cavities, or halitosis as an outcome of taping. The 2025 systematic review that pooled the literature has a column in its outcomes table for dry mouth, and the column is empty.
This is an important distinction and I want to hold onto it for the rest of the piece. There is a difference between a claim that has been tested and failed, and a claim that has never been tested at all. Most of what mouth tape is sold for falls in the second category. It isn't weakly supported. It's unexamined.
There is a difference between a claim that failed and a claim nobody ever ran. Most of what mouth tape is sold for has never been measured.
Dr. Maren ColeTen Studies, 233 Patients, One Randomized Trial, All Rated Poor
In May 2025, a team at Western University in Ontario published the first and only systematic review of mouth taping.1 They searched MEDLINE and Embase from 1999 through February 2024, screened 120 records, pulled 24 full texts, and ended up with ten studies. Ten. Total enrollment across all of them was roughly 233 patients, with individual sample sizes running from nine to seventy-one.
Of those ten, one was a randomized controlled trial. Six were prospective cross-sectional studies. The rest were cohort or crossover designs. When the reviewers applied the Newcastle-Ottawa Scale — a standard risk-of-bias tool for observational research — all ten studies came back rated poor. Nine of ten had no adequate follow-up. Six never stated what confounders they adjusted for. The heterogeneity was severe enough that a meta-analysis was impossible; the reviewers couldn't statistically pool a single outcome.
Six studies measured the apnea-hypopnea index, the standard metric for sleep apnea severity. Two found a significant reduction. Three found nothing. The two that worked are worth looking at closely, because they are the studies underneath essentially all mouth tape marketing.
The only systematic review of mouth taping. Pooled every published study on mouth taping or oral occlusion in patients with mouth breathing, sleep-disordered breathing, or obstructive sleep apnea. Ten studies, one of them randomized. PROSPERO-registered, and the authors declared no funding and no competing interests.1
Conclusion, verbatim: "The existing data does not support mouth taping or oral occlusion as a sound clinical intervention for the general population with sleep disordered breathing." The abstract adds that "there is a potentially serious risk of harm for individuals indiscriminately practicing this trend."
Limitation: All ten included studies rated poor on the Newcastle-Ottawa Scale, nine lacked adequate follow-up, and heterogeneity prevented any meta-analysis — so the review can characterize the literature but cannot pool it into an effect estimate.
The most-cited positive result. Twenty patients at Chang Gung Memorial Hospital in Taiwan, all with mild obstructive sleep apnea (AHI under 15), all confirmed mouth breathers, median BMI 24.5.2
Results: Median AHI fell from 8.3 to 4.7 events per hour, a 47% drop (p=0.0002). Snoring index fell 60%, from 303.8 to 121.1 (p=0.0002). Lowest oxygen saturation improved from 82.5% to 87%. Mean oxygen saturation did not change.
Limitation: Retrospective, unblinded, no control group, no follow-up, and only 13 of 20 patients responded — it failed in a third. The authors' own caution: mouth taping "is not recommended for moderate or severe OSA patients because it may impose dangers rather than benefits."
The second positive study, from 2015, tested a porous oral patch in thirty patients with mild apnea and found median AHI dropped from 12 to 7.8 events per hour, with a large reduction in snoring.3 Those authors were equally candid: their paper "does not define the safety or efficacy due to a small single-institution case series without a control group."
Read that pair carefully and notice what they have in common. Both were conducted in patients with mild apnea. Both were run on patients screened and confirmed to breathe through their mouths at night. And both moved patients from mild apnea to mild apnea. A median AHI of 4.7 is better than 8.3, and I'm not going to pretend otherwise — but it is not a cure, it is not a treatment for the disease most people are worried about, and it was measured without a control group in twenty people.
One more thing about who these trials studied. Four of the ten included studies explicitly excluded anyone with nasal obstruction. The evidence suggesting mouth taping might help was generated exclusively in people whose noses definitely worked. Hold that thought.
The Trial Where Closing the Mouth Made Breathing Worse
The three studies that found nothing are as informative as the two that found something.
A 2022 crossover study of twenty-one patients found that tape added to a mandibular advancement device beat the device alone — median AHI 5.6 versus 10.5.4 But tape by itself, compared to baseline, produced no significant difference. It worked as an accessory to an actual medical device, not as an intervention. The single randomized controlled trial in the entire literature enrolled ten patients with a mean AHI of 47 and tested tape plus a chinstrap plus nasal spray against placebo. No significant difference in AHI.5 And a 2014 chinstrap study of twenty-six patients found no AHI improvement at all, plus a drop in REM sleep from 20.2% to 8.7%.6
Then there's the study that I think should be the centerpiece of any honest conversation about this trend, and which almost nobody in the wellness world has mentioned.
Airflow measured directly, not inferred. Fifty-four patients with obstructive sleep apnea (median AHI 26.9) underwent drug-induced sleep endoscopy while researchers closed their mouths by manual chin pressure and measured airflow in real time.7
Results: Airflow improved by 2.0 L/min in the 32 patients with moderate mouth breathing. But in the 12 patients who breathed primarily through their mouths and had velopharyngeal obstruction, airflow got worse — by 1.9 L/min (95% CI −3.1 to −0.6). The authors' conclusion: in these patients, "airflow worsens with mouth closure."
Limitation: This used manual chin pressure during induced sleep, not tape over a full night, and it was not randomized. One author discloses personal fees and grants from a mouth-strip manufacturer.
This is the mechanism by which mouth taping can hurt someone, demonstrated under direct measurement. For a subset of people with soft-palate collapse, the open mouth is not the problem — it's the compensation. Close it and you make things worse.
The obvious question is how you'd know which group you're in. The answer is that you can't, not without a sleep study. And that turns out to be the crux of the whole thing.
The literature fits in a lecture hall. The market does not.1,9,11
Where the Pediatric Science Gets Laundered
Now to the claim that sells the most tape and has the least behind it.
The jawline promise borrows its credibility from a real body of pediatric research. Children who breathe through their mouths chronically do show differences in craniofacial development. A 2021 meta-analysis pooled ten studies and 1,358 children aged two to fourteen and found measurable skeletal differences: a steeper mandibular plane angle, altered SNA and SNB angles.12 These are real findings in a real literature.
Read past the abstract, though, and the picture changes. All ten studies were retrospective and observational — zero randomized trials. The authors' own GRADE assessment rated the certainty of evidence as low for sixteen of seventeen outcomes. The abstract omits four null results, including overjet and overbite, which are the two measures a layperson would actually see when looking at a face. And critically, the mouth-breathing children studied had adenoid or tonsil hypertrophy, sleep-disordered breathing, or allergic rhinitis. They had airway pathology. They did not have a taping habit they'd neglected to adopt.
The field's own summary is blunt. A 2022 review in Frontiers in Public Health states that "there is no high-quality evidence elucidating the effects of mouth breathing on dentofacial development and health," and notes there aren't even strict criteria for diagnosing mouth breathing in the first place.13 The word "adult" does not appear anywhere in that paper.
Which brings us to the anatomy problem. Adults who buy mouth tape hoping to reshape their jaw are working against a fused skeleton. A 2013 CBCT study of 140 subjects aged 5.6 to 58.4 established the staging system orthodontists use for midpalatal suture fusion — and the entire clinical purpose of that classification is to identify which patients require surgically assisted palatal expansion because the suture has closed.14 Moving an adult maxilla takes a jackscrew and an osteotomy. It is a surgical procedure. A strip of tape is not a surgical procedure.
The American Association of Orthodontists addressed the adjacent "mewing" trend directly in January 2024. Their president: "While proper tongue posture plays a role in oral health and development, mewing oversimplifies the complexities of facial structure. There's no scientific evidence to support its claims of reshaping the jawline, and the potential risks outweigh any unproven benefits."15 The oral surgery literature reached the same place five years earlier, in a letter concluding the practice "is not based on sound scientific evidence."16
There is one genuinely effective intervention in this neighborhood, and it's the one mouth tape gets confused with. Myofunctional therapy — structured daily exercise of the tongue, palate, and facial muscles — has a 2015 meta-analysis behind it showing adult AHI dropping from 24.5 to 12.3 events per hour across 120 patients, roughly a 50% reduction.17 That's a real result. It is also thirty minutes a day of active muscular work, which is approximately the opposite of putting on a strip of tape and going to sleep. And that meta-analysis measured zero facial-appearance outcomes.
Moving an adult maxilla takes a jackscrew and an osteotomy. It is a surgical procedure. A strip of tape is not a surgical procedure.
On the jawline claimThe Only Dermatologic Outcome With Data Behind It Is the Rash
This is my column, so let me be direct about the skin claim.
No study of mouth taping has ever measured a skin outcome. The claim that mouth breathing dries out facial skin has, as far as I can find, no source at all — it traces to retailer copy. It's also mechanistically implausible. Exhaled air exits away from the face, and stratum corneum hydration is governed by ambient humidity and barrier function, not by which orifice you breathe through.
The one real human study anywhere near this question runs the wrong direction for the people selling tape. A 2015 cross-sectional study of 468 Japanese children found mouth breathing associated with more atopic dermatitis, not less (daytime odds ratio 2.4, 95% CI 1.4–4.2).18 That is almost certainly reverse causation — atopy causes rhinitis, rhinitis causes congestion, congestion causes mouth breathing. But it's the only skin-adjacent human data in the file, and it isn't a point in the tape's favor.
Meanwhile, there is one dermatologic effect of mouth taping with genuine published evidence behind the mechanism, and it's the adhesive. Medical adhesive-related skin injury is a well-characterized entity. Acrylate and polyurethane adhesives are the most frequently implicated, and severe adhesive-related skin tears are documented as occurring almost always on the face. Irritant contact dermatitis is common; true allergic contact dermatitis is less so but real.
I'll caveat this honestly: that literature comes from hospitalized patients with medical tape on compromised skin, and nobody has measured the incidence of adhesive injury in healthy people taping their mouths at home. But the single relevant adverse event report in the FDA's MAUDE database — filed in July 2026 against a hypoallergenic mouth tape — describes exactly this. A consumer bought it at Walmart for his sleep apnea, noticed sticky residue around his mouth, and developed a rash by the third use.19
Two things in that one report. The harm was dermatologic. And he bought it for sleep apnea.
So the honest summary for a skincare readership: people are applying a nightly adhesive application-and-removal cycle to thin, mobile perioral skin, in pursuit of a skin benefit that has never once been measured in a study. That's not a scare story. It's just the actual balance of evidence, and it happens to point the opposite way from the marketing.
Eight in Ten People Don't Know What They're Taping Over
Let me be scrupulous here, because this is where coverage of mouth taping tends to get overheated.
There is no published case report of death, asphyxiation, or aspiration from nocturnal mouth taping. No coroner report, no emergency department series. Anyone telling you mouth taping has killed people is not working from the literature. The FDA has issued no warning letters, no safety communications, and no recalls on mouth tape.
The safety case is mechanistic rather than event-based, and four of the ten studies in the systematic review carry explicit author warnings. The 1999 study that first tested taping alongside nasal bilevel therapy stated that the authors "do not at this stage advocate taping the mouth for indiscriminate long-term home use, because of the risk of asphyxia in the presence of nasal obstruction, machine or power failure, or regurgitation."8 Another warned about aspiration of stomach contents in someone who regurgitates and can't clear it.
The real problem is denominator. The Wisconsin Sleep Cohort — 4,925 employed adults, with polysomnography in 1,090 of them — estimated that 93% of women and 82% of men with moderate-to-severe sleep apnea had never been clinically diagnosed.9 That was in an employed population with insurance and access to care. Worldwide, an estimated 936 million adults aged 30 to 69 have mild-to-severe obstructive sleep apnea; 425 million have the moderate-to-severe form.10
Put those together with the trend and you get the actual risk. Mouth tape reliably reduces snoring — that's the most consistent finding in the whole literature, positive in every study that measured it. Snoring is also, for a great many people, the symptom that eventually sends them or their partner to a sleep clinic. Suppress the symptom, keep the disease. Brian Rotenberg, senior author of the systematic review, put the broader problem plainly: "The purported benefits that are being touted for this — improving apnea, improving snoring, making your nose look better, making your jaw look better — it just doesn't come out in the wash that that actually is what's happening."
Undiagnosed Sleep Apnea
Roughly eight in ten adults with moderate-to-severe OSA have never been diagnosed. Tape can suppress the snoring that would otherwise have led to a diagnosis, masking the symptom while the disease continues.
Nasal Obstruction
Deviated septum, polyps, allergic rhinitis, chronic congestion. Four of the ten studies in the review excluded these patients — meaning the evidence for benefit came exclusively from people who definitely didn't need their mouths.
Reflux, Alcohol and Sedatives
Study authors have flagged the possibility of aspirating stomach contents if you regurgitate and can't clear it. Hostage Tape's own label says do not use after alcohol or sedatives — a warning absent from the marketing that sells it.
Perioral Contact Dermatitis
The one adverse event report on file with the FDA describes a rash around the mouth after three nights. Acrylate adhesives drive most adhesive-related skin injury, and facial skin is thin, mobile, and repeatedly stripped.
Worth noting what does not exist: the American Academy of Sleep Medicine has no position statement, guideline, or health advisory on mouth taping. Neither does the American Academy of Otolaryngology, the American Dental Association, or any of the major British or European respiratory bodies. What exists is a 2023 AASM press release in which spokesperson Dr. John Saito said that viral sleep trends are "at best unproven, but at worst — like mouth taping — they can be extremely dangerous."20 That's a spokesperson quote, not an institutional position, and anyone citing it as a formal recommendation is overstating it. The one signed editorial I found came from the American Academy of Dental Sleep Medicine's editor-in-chief in April 2025: "There is currently no supporting evidence for most other claimed benefits, including improved oral health."21
The regulatory picture is similarly thin. No mouth tape has an FDA 510(k) clearance — I checked all three plausible product codes and found none. What brands have instead is establishment registration, which is a paid annual self-declaration; the regulation itself states that registration "does not in any way denote approval of the establishment or its products." One major brand is listed under the product code for nasal dilators, with an empty clearance field. Australia's regulator has gone so far as to create a device category called "nasal breathing mouth tape," all of it Class 1, sponsor self-certified, with no efficacy assessment.
And the information environment is exactly what you'd expect. A 2026 content analysis pulled 390 mouth-taping reels from Instagram's API: 94.4% supportive, 3.8% critical, 55.4% posted by companies, 11.6% from medical accounts, and 1.3% educational. Supportive posts were shared nearly five times more often than critical ones (mean 923 versus 193, p=0.015).11
Who is actually talking about mouth taping. 530 reels retrieved via the Instagram Graph API in April 2025, 390 analyzed for stance, source type, and engagement.11
Results: 368 posts (94.4%) supported mouth taping; 15 (3.8%) opposed it. Companies produced 55.4% of the content, medical profiles 11.6%, and only 1.3% was educational. Supportive posts were shared far more (mean 923 vs 193, p=0.015). The authors: content "overwhelmingly promotes mouth-taping, largely driven by commercial actors."
Limitation: One platform, one month of sampling, and engagement metrics cannot separate algorithmic amplification from genuine persuasion.
An Accounting, Not a Debunking
I don't think mouth taping is a scam, and I'm not going to write it as one. That would be as unearned as the marketing.
What it is, is a product whose evidence base and whose market share almost no overlap. The claims deserve different verdicts, and the most useful thing I can do is give them separately.
Reduced snoring in confirmed nasal breathers is the strongest claim, and I'd call it promising. Every study that measured a snoring index found a reduction, and the effect sizes were large. The study quality is poor across the board, but the signal is the most consistent thing in the literature.
Improving mild sleep apnea in screened mouth breathers is insufficient data. Two of six studies positive, both small, both retrospective, both moving patients from mild to mild. Not nothing. Not a treatment.
Treating moderate or severe sleep apnea is where I'd use the word hype, and add unsafe. Three studies including the only randomized trial found no benefit, the JAMA Otolaryngology work shows airflow can actively worsen, and the authors of the most-cited positive trial say explicitly not to do it.
The jawline, the skin, and the energy claims are marketing hype by the plainest definition: claims that dramatically exceed evidence that does not exist. Zero studies of any design have measured any of them. For the jawline specifically, the anatomy makes it not merely unproven but implausible in adults.
Weighed as a whole, I'm rating mouth taping Insufficient Data. That's more honest than Marketing Hype, because the snoring signal is real and consistent across every study that looked for it. And it's more honest than Promising, because every one of those studies was rated poor quality, the only randomized trial was negative, and the trials that found benefit systematically excluded the people most likely to buy the product.
If you have a confirmed clear nasal airway, no reflux, no sedatives or alcohol at night, and a sleep study on file showing you don't have moderate or severe apnea, then trying mouth tape for snoring is a low-stakes experiment with a plausible upside. That is a narrow set of conditions, and almost nobody buying tape has checked all four.
If you snore and you have never had a sleep study, the tape is the wrong purchase. The right one is the sleep study. Suppressing the noise that would have gotten you diagnosed is the single worst outcome available here, and it's also the one the product is best at producing.
And if you came for the jawline or the skin: there is no study. Not a weak study, not a conflicted study. None. The only dermatologic outcome of mouth taping with any human data behind its mechanism is the rash from the adhesive.
Mouth tape reliably quiets snoring in people whose noses already work — and that's the whole verified list. The jawline, the skin, and the energy were never measured by anyone. If you snore and haven't had a sleep study, buy the sleep study, not the tape.
- 1. Rhee J, Iansavitchene A, Mannala S, Graham ME, Rotenberg B. Breaking social media fads and uncovering the safety and efficacy of mouth taping in patients with mouth breathing, sleep disordered breathing, or obstructive sleep apnea: A systematic review. PLOS One. 2025;20(5):e0323643. PROSPERO CRD42024509650.
- 2. Lee YC, Lu CT, Cheng WN, Li HY. The Impact of Mouth-Taping in Mouth-Breathers with Mild Obstructive Sleep Apnea: A Preliminary Study. Healthcare (Basel). 2022;10(9):1755.
- 3. Huang TW, Young TH. Novel porous oral patches for patients with mild obstructive sleep apnea and mouth breathing: a pilot study. Otolaryngology–Head and Neck Surgery. 2015;152(2):369–373.
- 4. Labarca G, et al. Efficacy of Oral Appliance Therapy With and Without Mouth Taping. Annals of the American Thoracic Society. 2022;19(7):1185–1192.
- 5. Osman A, et al. Randomized controlled trial of nasal breathing promotion in obstructive sleep apnea. American Journal of Physiology–Heart and Circulatory Physiology. 2024;326(3):H715–H723.
- 6. Bhat S, et al. The efficacy of a chinstrap in treating sleep disordered breathing and mouth leak. Journal of Clinical Sleep Medicine. 2014;10(8):887–892.
- 7. Yang H, Huyett P, Wellman A, Vena D, et al. Mouth Closure and Airflow in Patients With Obstructive Sleep Apnea: A Nonrandomized Clinical Trial. JAMA Otolaryngology–Head & Neck Surgery. 2024;150(11):1012–1019.
- 8. Teschler H, et al. Effect of mouth leak on effectiveness of nasal bilevel ventilatory assistance and sleep architecture. European Respiratory Journal. 1999;14(6):1251–1257.
- 9. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20(9):705–706. Wisconsin Sleep Cohort, 4,925 adults.
- 10. Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. The Lancet Respiratory Medicine. 2019;7(8):687–698.
- 11. Bizzoca ME, et al. The Spread of Non-Evidence-Based Health Claims on Social Media: The Case of #Mouthtape on Instagram, a Cross-Sectional Study. Dentistry Journal. 2026;14(7):418.
- 12. Zhao Z, Zheng L, Huang X, Li C, Liu J, Hu Y. Effects of mouth breathing on facial skeletal development in children: a systematic review and meta-analysis. BMC Oral Health. 2021;21:108. Ten studies, 1,358 children.
- 13. Lin L, Zhao T, Qin D, Hua F, He H. The impact of mouth breathing on dentofacial development: A concise review. Frontiers in Public Health. 2022;10:929165.
- 14. Angelieri F, Cevidanes LHS, Franchi L, Gonçalves JR, Benavides E, McNamara JA Jr. Midpalatal suture maturation: classification method for individual assessment before rapid maxillary expansion. American Journal of Orthodontics and Dentofacial Orthopedics. 2013;144(5):759–769.
- 15. American Association of Orthodontists. Press release on the "mewing" trend, January 22, 2024. Statement of AAO President Myron Guymon, DDS, MS.
- 16. Lee UK, Graves LL, Friedlander AH. Mewing: Social Media's Alternative to Orthognathic Surgery? Journal of Oral and Maxillofacial Surgery. 2019;77(9):1743–1744.
- 17. Camacho M, Certal V, Abdullatif J, Zaghi S, Ruoff CM, Capasso R, Kushida CA. Myofunctional therapy to treat obstructive sleep apnea: a systematic review and meta-analysis. SLEEP. 2015;38(5):669–675.
- 18. Yamaguchi H, et al. Association between Mouth Breathing and Atopic Dermatitis in Japanese Children 2–6 Years Old: A Population-Based Cross-Sectional Study. PLOS One. 2015;10(4):e0125916.
- 19. U.S. Food and Drug Administration, MAUDE adverse event database. Report MW5190615, received July 13, 2026.
- 20. American Academy of Sleep Medicine. "Viral TikTok trends are not the answer for better sleep." Press release, July 25, 2023. Survey n=2,005 U.S. adults; follow-up survey June 2025, n=2,007.
- 21. Masse JF. Editorial. Journal of Dental Sleep Medicine. 2025;12(2). American Academy of Dental Sleep Medicine.
- 22. Virtue Market Research. Global Mouth Tape Market: USD 0.18 billion (2024), projected USD 0.33 billion by 2030.
- 23. U.S. Food and Drug Administration. General Wellness: Policy for Low Risk Devices — final guidance, January 2026; and 21 CFR 807.39 on establishment registration.